General Insurance Corporation of India

Investment decisions are overseen by the Chairman and Managing Director, Ramswaroop Gupta, alongside GIC Re's board, which includes nominees from the Government of India. The firm's investment committee operates within regulatory mandates set by the Insurance Regulatory and Development Authority of India (IRDAI), which prescribe exposure limits for government securities, corporate bonds, and equities. Day-to-day portfolio execution is handled by an internal treasury team in Mumbai.

GIC Re receives a compulsory cession — a fixed percentage of every general insurance policy written by domestic primary insurers — by statutory mandate. This structural preference makes it the dominant reinsurer in India, though the exact cession rate has been progressively reduced by the regulator to encourage private competition. The firm also competes for voluntary treaty and facultative business alongside global players like Munich Re and Swiss Re.

GIC Re primarily invests its domestic float in Indian government securities, corporate bonds, and equities, but its overseas branch offices in London, Dubai, and Moscow enable it to underwrite international reinsurance risks and hold foreign-currency assets that match those liabilities. The firm's asset allocation is liability-driven, and foreign investments are managed conservatively within IRDAI's outward remittance limits.

Life Insurance Corporation of India (LIC) is GIC Re's largest minority shareholder with a 9.81% stake, creating a cross-holding relationship between India's two largest state-owned insurance entities. LIC focuses on life insurance, while GIC Re is exclusively a non-life reinsurer; their balance sheets and investment committees operate independently, but the shareholding reflects the Government of India's coordinated control over public-sector insurance capital.

GIC Re directs corporate social responsibility spending — mandatory under Indian law for profitable public-sector companies — toward healthcare and disability initiatives. Named grantees include Aravind Eye Hospitals for low-cost cataract surgery, the Mahesh Foundation, Samarthanam Trust for the Disabled, and Smile Foundation, all operating in India. These are funded from a regulatory-mandated CSR allocation, not a separate foundation vehicle.

Yes, GIC Re carries significant exposure to Indian catastrophe risk, particularly crop losses from monsoon failure and property claims from cyclones, floods, and earthquakes. Agriculture insurance, often government-subsidized through the Pradhan Mantri Fasal Bima Yojana, represents a large and volatile segment of its domestic portfolio. The firm manages this through retrocession treaties with international reinsurers and catastrophe reserve accumulation.

GIC Re is not known to participate in private market co-investments or club deals with external managers. Its investment portfolio is overwhelmingly allocated to public markets — sovereign debt, corporate credit, and listed equity — governed by strict regulatory asset-liability matching requirements. There is no public record of a private equity, venture capital, or alternative investment program.